Posted on December 3, 2010 by RachelB
As far back as 2008, the FDA has been hot on the trail of Merck–manufacturer of the Gardasil HPV vaccine that has come under continual scrutiny for its varying and sometimes severe side effects. Since its release in 2006, the vaccine has been met with strings of concerns from parents and loved ones of young women who have taken the vaccine and then days, sometimes weeks later fallen ill with almost unexplainable and life-changing illnesses like ALS (Lou Gehrig’s disease), seizures, and weakness that is unexplainable. Most disturbing, is that the FDA has been warning Merck’s manufacturing division about laboratory procedures that were not “scientifically sound”, and questioning the quality of the vaccines produced.
Until this current day, investigating agencies like the FDA and the CDC call the majority of these reactions “circumstantial” and are yet to admit a significant link between the vaccine and complications. As recently at this month, the pharmaceutical company is going to be beefing up its marketing campaign to try to boost a sagging vaccination rate among the female population group. The vaccine, which is now also being recommended for boys is marketed to prevent four strains of the HPV virus that are linked to cervical cancer in females, and anal cancers in males. Despite its marketing hype, the vaccine is still met with a wide base of speculation and concern–especially after fears and irreversible damages have surfaced, and it only makes sense that it stems from the vaccine–regardless of what the FDA says.
In 2008, the FDA warned Merck’s manufacturing plant based in Pennsylvania that laboratory procedures were sub par, and cited “strength, quality, and purity” of the products as being questionable. The FDA stated that the company has had a track record of not evaluating the strength of measles, mumps and rubella (MMR) vaccines on multiple occasions. The release of the warning letter by the FDA is a red flag that signals multiple attempts by the FDA to have Merck take corrective action against the problems. Instead of responding with changes, the company has continued to manufacture vaccines without heeding the government’s warnings for change. The Association also says that Merck “failed to thoroughly investigate” variances between some batches of vaccines that were manufactured in the plant, and continued to distribute the products for us.